Skip to main content
. 2021 May 15;26(10):2943. doi: 10.3390/molecules26102943

Figure 3.

Figure 3

Structures of different linker groups used in ADCs. (a) A cleavable hydrazone linker and disulphide trigger as used in Mylotarg®; (b) an MC–Val–Cit–PABC linker, combining the non-cleavable MC and dipeptide cleavable Val–Cit linkers with a PABC spacer, as used in Adcetris®; (c) a non-cleavable MCC linker as used in Kadcyla®.